Effect of Using Dextrose-containing Intraoperative Fluid in Children

Sponsor
Mahidol University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05061836
Collaborator
(none)
68
1
4
14
4.9

Study Details

Study Description

Brief Summary

The glucose-containing fluid was preferred for maintenance fluid in pediatric surgery to prevent hypoglycemic events. This practice can lead to intraoperative hyperglycemia which can induce osmotic diuresis and consequently dehydration and electrolyte disturbances.

As an anesthesiologist, the use of glucose-containing fluid should be reconsidered to avoid these undesirable effects in pediatric surgery.

Our study aims to identify an appropriate use of 5% dextrose containing solution during intraoperative period in children (2 age groups: 1-2 vs 3-5 years old) that can prevent glucose and lipid mobilization without causing hypo/hyperglycemia and provide adequate fluid maintenance in the context of hospitals in Thailand

Condition or Disease Intervention/Treatment Phase
  • Drug: Ringer acetate
  • Drug: 1.25%Dextrose equivalence
  • Drug: 2.5%Dextrose equivalence
  • Drug: Dextrose 5
N/A

Detailed Description

  • In this randomized controlled trial, the investigator will find the difference in pre and postoperative value of base excess among the different fluid groups which is an acid-base parameter indicating volume status and mobilization of lipid stores in each age group (2 age group: 1-2 vs 3-5 years old). Each age group will be divided to:
  1. Group D0: patients will receive Acetate Ringer's solution (Acetar) infused at maintenance rate

  2. Group D1: 5%dextrose in normal saline (5%DNSS) infused ¼ of maintenance rate [resulted in 1.25%dextrose equivalence]

  3. Group D2: 5%DNSS infused ½ of maintenance rate [resulted in 2.5%dextrose equivalence]

  4. Group D5: 5%DNSS infused with maintenance rate

  • Patient will be fasting as standard preoperative fasting protocol, and received 5 ml/kg of water at 3 hours prior to surgery

  • After standard anesthesia induction and intravenous line (IV) placement, the blood samples will be collected and the POCT glucose will be re-evaluated every 1 hour through the operation to avoid intraoperative hypo/hyperglycemia.

  • The first blood sample will be collected after IV line placement and the second blood sample will be collected at the end of surgery. Both blood samples will be sent to the lab to measure blood glucose, serum electrolytes (sodium, potassium, and chloride), acid-base parameters (pH, base excess, standardized bicarbonate, anion gap), endocrine parameters (serum insulin, glucagon, cortisol), and metabolic parameters (free fatty acid, serum ketone, serum lactate).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Using Dextrose-containing Intraoperative Fluid in Children: a Randomized Controlled Trial
Anticipated Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dextrose0

Acetate Ringer's solution

Drug: Ringer acetate
Patient will receive Acetate Ringer's solution (Acetar) infused at maintenance rate

Experimental: Dextrose1

1.25%dextrose equivalence

Drug: 1.25%Dextrose equivalence
5%dextrose in normal saline (5%DNSS) infused ¼ of maintenance rate

Experimental: Dextrose2

2.5%dextrose equivalence

Drug: 2.5%Dextrose equivalence
5%dextrose in normal saline (5%DNSS) infused ½ of maintenance rate

Active Comparator: Dextrose5

5%dextrose

Drug: Dextrose 5
5%dextrose in normal saline (5%DNSS) infused with maintenance rate

Outcome Measures

Primary Outcome Measures

  1. The difference in pre and postoperative value of base excess [1 day]

    To find the difference in pre and postoperative value of base excess among the different fluid groups which is an acid-base parameter indicating volume status and mobilization of lipid stores in each age group.

Secondary Outcome Measures

  1. The difference in postoperative value of other acid-base, metabolic, and endocrine parameters [1 day]

    To find the difference in postoperative value of other acid-base, metabolic, and endocrine parameters that indicate mobilization of glucose and lipid stores of each group with different maintenance rate of fluid in each age group and between age group.

  2. Incidence of postoperative base excess value that equal or more negative than -5 of each group [1 day]

    To find the incidence of postoperative base excess value that equal or more negative than -5 of each group with different maintenance rate of fluid in each age group and between age group.

  3. The difference in perioperative blood glucose level among the groups [1 day]

    To find the difference in perioperative blood glucose level among the groups measured during surgery of each group with different maintenance rate of fluid in each age group and between age group.

  4. Incidence of hypotension of each group [1 day]

    To find the incidence of hypotension of each group with different maintenance rate of fluid in each age group and between age group

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Children aged of 1 to 5 years

  2. ASA physical status 1 and 2

  3. Schedule for elective non-abdominal surgery between 1-3 hours under general anesthesia without anticipation of major blood loss at Siriraj Hospital.

Exclusion Criteria:
  1. Patients with severe neurologic, cardiac, endocrine, or metabolic disease

  2. Patients receiving intravenous fluid preoperatively

  3. Patients with history or have known risk of hypoglycemia

  4. Patient with severe liver dysfunction

Withdrawal or termination criteria

  1. Patients requiring intraoperative blood product transfusion or inotropes infusion

  2. Patients who have preoperative hypoglycemia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Siriraj Hospital Bangkok noi Bangkok Thailand 10700

Sponsors and Collaborators

  • Mahidol University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
patcharee sriswasdi, MD, MPH, Mahidol University
ClinicalTrials.gov Identifier:
NCT05061836
Other Study ID Numbers:
  • 12345
First Posted:
Sep 30, 2021
Last Update Posted:
Sep 30, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by patcharee sriswasdi, MD, MPH, Mahidol University

Study Results

No Results Posted as of Sep 30, 2021